Data Collection of OCT and OCTA-based Ocular Measurements
Launched by OPTOVUE · Mar 20, 2019
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study is to collect measurements of anatomical structures of the posterior pole of the eye based on OCT scans in subjects without clinical signs of pathology.
Gender
Eligibility criteria
- Inclusion Criteria:
- • No glaucoma
- • No retinal pathology
- • No systemic disorders impacting the eye
- • No ocular surgery or medical treatment of ocular condition
- Exclusion Criteria:
- • High IOP
- • Poor vision
- • Clinical findings consistent with pathology
- • Unable to complete the study
About Optovue
Optovue is a leading innovator in the field of ophthalmic imaging and diagnostics, specializing in advanced optical coherence tomography (OCT) technology. With a commitment to enhancing vision health, Optovue develops cutting-edge tools that empower healthcare professionals to detect and monitor ocular conditions with precision and efficiency. The company's clinical trials aim to validate the efficacy and safety of its groundbreaking solutions, contributing to improved patient outcomes and advancing the standard of care in ophthalmology. Through rigorous research and a dedication to innovation, Optovue strives to transform the landscape of eye care and promote a deeper understanding of eye diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, New Jersey, United States
Pomona, California, United States
Fort Lauderdale, Florida, United States
Marysville, Ohio, United States
Tahlequah, Oklahoma, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials